Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |